Search results for "adaptive immunity"

showing 10 items of 69 documents

The Role of Immunosenescence in Cerebral Small Vessel Disease: A Review.

2022

Cerebral small vessel disease (CSVD) is one of the most important causes of vascular dementia. Immunosenescence and inflammatory response, with the involvement of the cerebrovascular system, constitute the basis of this disease. Immunosenescence identifies a condition of deterioration of the immune organs and consequent dysregulation of the immune response caused by cellular senescence, which exposes older adults to a greater vulnerability. A low-grade chronic inflammation status also accompanies it without overt infections, an “inflammaging” condition. The correlation between immunosenescence and inflammaging is fundamental in understanding the pathogenesis of age-related CSVD (ArCSVD). Th…

InflammationSettore MED/09 - Medicina InternaEndothelieal dysfunctionImmunosenescenceOrganic ChemistryGeneral MedicineAdaptive ImmunityCatalysisComputer Science ApplicationsArCSVDInorganic ChemistryCerebral Small Vessel DiseasesCSVDHumansinflammagingPhysical and Theoretical ChemistryInflammation MediatorsBBB leakageMolecular BiologySpectroscopyAgedInternational journal of molecular sciences
researchProduct

Microgravity-induced alterations in signal transduction in cells of the immune system

2010

Since decades it is known that the activity of cells of the immune system is severely dysregulated in microgravity, however, the underlying molecular aspects have not been elucidated yet. The identification of gravity-sensitive molecular mechanisms in cells of the immune system is an important and indispensable prerequisite for the development of counteractive measures to prevent or treat disturbed immune cell function of astronauts during long-term space missions. Moreover, their sensitivity to altered gravity renders immune cells an ideal model system to understand if and how gravity on Earth is required for normal mammalian cell function and signal transduction. We investigated the effec…

Innate immunityICAM-1Innate immune system10017 Institute of AnatomyChemistryAdaptive immunityAerospace Engineering610 Medicine & healthSpaceflightSignal transductionAcquired immune systemJurkat cellsCell biologyGravisensitivityImmune system2202 Aerospace EngineeringCell culture570 Life sciences; biologySignal transductionClinostatActa Astronautica
researchProduct

Immunological priming in the wood tiger moth (Parasemia plantaginis)

2014

Hyönteisiin lukeutuu monia merkittäviä tuholaisia, taudinvälittäjiä ja hyödyllisiä lajeja, minkä takia hyönteisten taudit, taudinaiheuttajat ja immuunipuolustus ovat ekologisesta, ekonomisesta ja lääketieteellisestä näkökulmasta tärkeitä tutkimuskohteita. Viimeaikaiset tutkimukset paljastavat hyönteisten ja muiden selkärangattomien immuunijärjestelmien pystyvän erikoistumaan ja luomaan pitkäkestoista immuniteettia. Jälkimmäinen ilmiö tunnetaan tieteellisissä artikkeleissa nimellä ”immunological priming”, jonka voisi kääntää suomeksi esimerkiksi ”immuunipohjustukseksi”. Immuunipohjustus on muistinkaltaista vastustuskykyä, joka auttaa elimistöä puolustautumaan tehokkaammin toistuvia tartuntoj…

Lepidopterainsect herbivoreimmuunijärjestelmäwithin generational immune priminghyönteisetinnate immune systemimmuniteettiadaptive immunitySerratia marcescenstäpläsiilikäs
researchProduct

Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients

2021

Information on the immunopathobiology of coronavirus disease 2019 (COVID-19) is rapidly increasing; however, there remains a need to identify immune features predictive of fatal outcome. This large-scale study characterized immune responses to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection using multidimensional flow cytometry, with the aim of identifying high-risk immune biomarkers. Holistic and unbiased analyses of 17 immune cell-types were conducted on 1,075 peripheral blood samples obtained from 868 COVID-19 patients and on samples from 24 patients presenting with non-SARS-CoV-2 infections and 36 healthy donors. Immune profiles of COVID-19 patients were significa…

Male0301 basic medicineMultivariate analysisSurvivalAdaptive ImmunityMonocytes0302 clinical medicineMedicineImmunology and AllergyFlow cytometryRespiratory systemYoung adultOriginal ResearchOutcomeAged 80 and overB-Lymphocytesmedicine.diagnostic_testMiddle AgedPrognosisAcquired immune systemmedicine.anatomical_structure030220 oncology & carcinogenesisoutcomebiomarkerFemaleAdultImmunologysurvivalFlow cytometryYoung Adult03 medical and health sciencesImmune systemLymphopeniaHumansAged 80 and overSurvival AnalysiSurvival analysisAgedbusiness.industrySARS-CoV-2Monocyteflow cytometrybiomarkersCOVID-19RC581-607Survival AnalysisImmunity Innate030104 developmental biologyImmunologyImmunologic diseases. AllergybusinessBiomarkersFrontiers in Immunology
researchProduct

DNA Methylation Analysis to Unravel Altered Genetic Pathways Underlying Early Onset and Late Onset Neonatal Sepsis. A Pilot Study

2021

Background: Neonatal sepsis is a systemic condition widely affecting preterm infants and characterized by pro-inflammatory and anti-inflammatory responses. However, its pathophysiology is not yet fully understood. Epigenetics regulates the immune system, and its alteration leads to the impaired immune response underlying sepsis. DNA methylation may contribute to sepsis-induced immunosuppression which, if persistent, will cause long-term adverse effects in neonates.Objective: To analyze the methylome of preterm infants in order to determine whether there are DNA methylation marks that may shed light on the pathophysiology of neonatal sepsis.Design: Prospective observational cohort study perf…

Male0301 basic medicinelcsh:Immunologic diseases. AllergyNeonatal intensive care unitgenetic structuresImmunologyPilot ProjectsLate onsetAdaptive ImmunityBioinformaticsCohort StudiesDiagnosis DifferentialSepsissepsis03 medical and health sciences0302 clinical medicineHumansImmunology and AllergyMedicineProspective StudiesEpigeneticsOriginal ResearchGenomeDNA methylationimmunosuppressionNeonatal sepsisbusiness.industryInfant Newbornneonatology and pediatric intensive careMethylationmedicine.diseaseImmunity Innate030104 developmental biologyinflammation030220 oncology & carcinogenesisDNA methylationBiomarker (medicine)FemaleNeonatal Sepsisbusinesslcsh:RC581-607Infant PrematureFrontiers in Immunology
researchProduct

Immune parameters identify Italian centenarians with a longer five-year survival independent of their health and functional status

2014

Centenarians are rare and exceptional individuals characterized by a peculiar phenotype. They are the best example of healthy aging in humans as most of them have escaped or substantially delayed the onset of major age-related diseases. Within this scenario, the purpose of the present work was to understand if immune status is associated with survival and health status in centenarians. To this aim, 116 centenarians were concomitantly characterized for their immunological, health and functional status, and followed-up for five-year survival. On the basis of previous knowledge we focused on a core of fundamental and basic immune parameters (number of leukocytes, monocytes, total lymphocytes, …

MaleAgingHelper T lymphocyteFrail ElderlyHealth StatusT-LymphocytesT cellCD3Kaplan-Meier EstimateType 2 diabetesAdaptive ImmunitycentenarianBiochemistryCD1903 medical and health sciences0302 clinical medicineEndocrinologyImmune systemGeneticsmedicineHumansCytotoxic T cellMolecular Biology030304 developmental biologyAged 80 and overSettore MED/04 - Patologia GeneraleB-Lymphocytes0303 health sciencesbiologyCell Biologyheath statumedicine.diseaseImmune parameters Centenarians Ageingmedicine.anatomical_structureDiabetes Mellitus Type 2CLUSTER ANALYSISImmunologySURVIVALbiology.proteinFemaleIMMUNE SYSTEMImmunologic Memory030217 neurology & neurosurgeryCD8Experimental Gerontology
researchProduct

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

2012

Background Hepatocellular carcinoma (HCC) is a typical inflammation-associated cancer, but may also provoke antitumour immune responses whose significance and underlying mechanisms are incompletely understood. Objective To characterise immune responses in the diethylnitrosamine (DEN)-liver cancer mouse model. Design Tumour development and immune cell functions upon DEN treatment were compared between C57BL/6 wild-type (WT), chemokine scavenging receptor D6-deficient, B cell- (Igh6), CD4 T cell- (MHC-II) and T-/B cell-deficient (Rag1) mice. Relevance for human HCC was tested by comparing gene array results from 139 HCC tissues. Results The induction of premalignant lesions after 24 weeks and…

MalePathologymedicine.medical_specialtyCarcinoma HepatocellularAdaptive ImmunityBiologyMajor histocompatibility complexChemokine CXCL9ArticleCCL5MiceLiver Neoplasms ExperimentalImmune systemAntigenLeukocytesmedicineAnimalsHumansCytotoxic T cellDiethylnitrosamineChemokine CCL5Chemokine CCL2B cellOligonucleotide Array Sequence AnalysisMice KnockoutB-LymphocytesMacrophagesLiver NeoplasmsGastroenterologyAcquired immune systemSurvival Analysisdigestive system diseasesMice Inbred C57BLmedicine.anatomical_structureCarcinogensDisease ProgressionCancer researchbiology.proteinPrecancerous ConditionsBiomarkersCD8T-Lymphocytes CytotoxicGut
researchProduct

RAPID AND EFFICIENT ANTIGEN PROCESSING AND PRESENTATION OF A PROTECTIVE AND IMMUNODOMINANT HLA-B*27-RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+T CELL …

2012

HLA-B*27 exerts protective effects in hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections. While the immunological and virological features of HLA-B*27-mediated protection are not fully understood, there is growing evidence that the presentation of specific immunodominant HLA-B*27-restricted CD8+ T-cell epitopes contributes to this phenomenon in both infections. Indeed, protection can be linked to single immunodominant CD8+ T-cell epitopes and functional constraints on escape mutations within these epitopes. To better define the immunological mechanisms underlying HLA-B*27-mediated protection in HCV infection, we analyzed the functional avidity, functional profile, ant…

MaleProteasome Endopeptidase ComplexQH301-705.5Immune CellsAntigen presentationImmunologyAntigen-Presenting CellsAntigen Processing and RecognitionHepacivirusBiologyAdaptive ImmunityCD8-Positive T-LymphocytesMicrobiologyEpitopeImmune ActivationMajor Histocompatibility ComplexEpitopesImmune systemVirologyGeneticsCytotoxic T cellHumansAvidityBiology (General)Antigen-presenting cellMolecular BiologyBiologyAntigen PresentationLinear epitopeAntigen processingT CellsImmunityRC581-607VirologyHepatitis CHLA-B AntigensImmunologyProteolysisQR180ParasitologyFemaleImmunologic diseases. AllergyHepatitis C AntigensResearch Article
researchProduct

Microbiota-Induced Type I Interferons Instruct a Poised Basal State of Dendritic Cells

2019

Summary Environmental signals shape host physiology and fitness. Microbiota-derived cues are required to program conventional dendritic cells (cDCs) during the steady state so that they can promptly respond and initiate adaptive immune responses when encountering pathogens. However, the molecular underpinnings of microbiota-guided instructive programs are not well understood. Here, we report that the indigenous microbiota controls constitutive production of type I interferons (IFN-I) by plasmacytoid DCs. Using genome-wide analysis of transcriptional and epigenetic regulomes of cDCs from germ-free and IFN-I receptor (IFNAR)-deficient mice, we found that tonic IFNAR signaling instructs a spec…

MaleReceptor Interferon alpha-betaAdaptive ImmunityCD8-Positive T-LymphocytesBiologyGeneral Biochemistry Genetics and Molecular BiologyMice03 medical and health sciences0302 clinical medicineImmune systemAntigenAnimalsEpigeneticsReceptor030304 developmental biologyEpigenomics0303 health sciencesMicrobiotaPeripheral toleranceDendritic Cellsperipheral toleranceCell biologyMice Inbred C57BLtype I interferonsplasmacytoid dendritic cellsconventional dendritic cellsInterferon Type IFemale030217 neurology & neurosurgerySignal TransductionCell
researchProduct

Tumor vaccination using messenger RNA: prospects of a future therapy.

2011

While the endeavor to vaccinate against cancer has been pursued for over 20 years, only recently was the first tumor vaccine approved. Among the different antigen formats assessed for vaccination, coding messenger RNA (mRNA) is emerging as a particularly attractive option. It can code for all types of transcript based proteins, is easy and cost efficient to produce, has a favorable safety profile and enables induction of combined immune responses. Within the last few years major developments have been achieved in this field. Clinical approaches use mRNA either for direct administration or for engineering of adoptively transferred dendritic cells. However, there are still challenges to be ov…

Messenger RNAClinical Trials as TopicImmunologyRNACancerDendritic CellsBiologyAdaptive Immunitymedicine.diseaseAcquired immune systemCancer VaccinesVaccinationSafety profileImmune systemAntigenNeoplasmsImmunologymedicineImmunology and AllergyAnimalsHumansRNA MessengerCurrent opinion in immunology
researchProduct